Citigroup’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-104,573
Closed -$4.02M 5067
2023
Q2
$4.02M Sell
104,573
-43,237
-29% -$1.66M ﹤0.01% 1218
2023
Q1
$3.42M Buy
147,810
+69,615
+89% +$1.61M ﹤0.01% 1279
2022
Q4
$2.05M Sell
78,195
-53,812
-41% -$1.41M ﹤0.01% 1508
2022
Q3
$2.6M Buy
132,007
+87,710
+198% +$1.72M ﹤0.01% 1441
2022
Q2
$775K Buy
44,297
+29,457
+198% +$515K ﹤0.01% 2273
2022
Q1
$243K Sell
14,840
-45,001
-75% -$737K ﹤0.01% 3300
2021
Q4
$976K Buy
59,841
+24,957
+72% +$407K ﹤0.01% 2584
2021
Q3
$445K Sell
34,884
-7,648
-18% -$97.6K ﹤0.01% 2962
2021
Q2
$601K Buy
42,532
+40,846
+2,423% +$577K ﹤0.01% 2941
2021
Q1
$26K Sell
1,686
-2,194
-57% -$33.8K ﹤0.01% 4438
2020
Q4
$62K Buy
3,880
+3,242
+508% +$51.8K ﹤0.01% 3979
2020
Q3
$8K Sell
638
-1,157
-64% -$14.5K ﹤0.01% 4462
2020
Q2
$21K Sell
1,795
-2,151
-55% -$25.2K ﹤0.01% 4220
2020
Q1
$54K Buy
3,946
+1,316
+50% +$18K ﹤0.01% 3748
2019
Q4
$16K Buy
2,630
+854
+48% +$5.2K ﹤0.01% 4573
2019
Q3
$9K Sell
1,776
-2,228
-56% -$11.3K ﹤0.01% 4630
2019
Q2
$31K Sell
4,004
-1,056
-21% -$8.18K ﹤0.01% 4394
2019
Q1
$101K Buy
5,060
+1,979
+64% +$39.5K ﹤0.01% 3573
2018
Q4
$41K Sell
3,081
-17
-0.5% -$226 ﹤0.01% 4046
2018
Q3
$114K Buy
+3,098
New +$114K ﹤0.01% 3494
2018
Q2
Sell
-46
Closed -$2K 5123
2018
Q1
$2K Sell
46
-11,427
-100% -$497K ﹤0.01% 4780
2017
Q4
$430K Buy
11,473
+5,149
+81% +$193K ﹤0.01% 2455
2017
Q3
$337K Buy
6,324
+6,270
+11,611% +$334K ﹤0.01% 2665
2017
Q2
$3K Sell
54
-21
-28% -$1.17K ﹤0.01% 4479
2017
Q1
$4K Sell
75
-7,999
-99% -$427K ﹤0.01% 4536
2016
Q4
$460K Buy
8,074
+5,286
+190% +$301K ﹤0.01% 2955
2016
Q3
$174K Sell
2,788
-72
-3% -$4.49K ﹤0.01% 3062
2016
Q2
$162K Sell
2,860
-265
-8% -$15K ﹤0.01% 3005
2016
Q1
$201K Buy
3,125
+914
+41% +$58.8K ﹤0.01% 3474
2015
Q4
$311K Buy
2,211
+2,190
+10,429% +$308K ﹤0.01% 2719
2015
Q3
$2K Sell
21
-1
-5% -$95 ﹤0.01% 4934
2015
Q2
$3K Buy
+22
New +$3K ﹤0.01% 5090